PhotoniCare, Inc.
PhotoniCare is dedicated to revolutionizing healthcare by providing better diagnostic tools for frontline care, especially in pediatric ear infections. Their mission is to improve clinical outcomes and serve unmet needs by translating light-based technologies into medical practice. Their flagship product, the OtoSight Middle Ear Scope, uses advanced Optical Coherence Tomography (OCT) technology to enable accurate, non-invasive diagnosis and monitoring of middle ear conditions, aiming to reduce misdiagnosis, unnecessary antibiotic use, and improve patient care.
Industries
Nr. of Employees
small (1-50)
PhotoniCare, Inc.
2800 Meridian Parkway, Suite 175, Durham, NC 27713
Patents
Products
OtoSight Middle Ear Scope
A handheld diagnostic imaging device that combines true-color otoscopy with depth-resolved optical coherence tomography to non-invasively visualize and characterize middle ear contents through the tympanic membrane.
OtoSight Middle Ear Scope
A handheld diagnostic imaging device that combines true-color otoscopy with depth-resolved optical coherence tomography to non-invasively visualize and characterize middle ear contents through the tympanic membrane.
Services
Assistance with billing, CPT code utilization, training on coding workflows, and appeals support for device-related services.
Short-term trial deployments, staff training for screening workflows, and co-marketing support for early-adopter clinical sites.
Personalized demos and consultations to show device capabilities and support clinical adoption decisions.
Assistance with billing, CPT code utilization, training on coding workflows, and appeals support for device-related services.
Short-term trial deployments, staff training for screening workflows, and co-marketing support for early-adopter clinical sites.
Personalized demos and consultations to show device capabilities and support clinical adoption decisions.
Expertise Areas
- Middle ear diagnostics and otology imaging
- Handheld point-of-care biomedical imaging
- Clinical trial management for medical devices
- Regulatory clearance and quality management for devices
Key Technologies
- Optical coherence tomography (OCT)
- Handheld optical imaging hardware
- Real-time color video otoscopy
- Depth-resolved imaging
News & Updates
Imaging Platform PhotoniCare Wins Top Prize at SPIE Startup Challenge at Photonics West
PhotoniCare's OtoSight Middle Ear Scope won a top prize at SPIE Photonics West, enabling doctors to see through eardrum tissue and visualize middle ear conditions with high resolution.
PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear
PhotoniCare received FDA 510(k) clearance for its OtoSight Middle Ear Scope, a non-invasive imaging device that helps determine the presence and type of fluid in the middle ear.
PhotoniCare Announces Rebranding of First-in-Class Technology for Imaging the Middle Ear, Now called OtoSight Middle Ear Scope
The company rebranded its technology to OtoSight Middle Ear Scope, emphasizing its innovative approach to diagnosing middle ear infections.
PhotoniCare Receives $2.1 Million NIH Phase IIb SBIR Award
PhotoniCare was awarded a $2.1 million grant from NIH to support expanded clinical trials of its OtoSight device for diagnosing middle ear disease.
PhotoniCare Appoints Former Welch Allyn CEO Steve Meyer to Advisory Board
Steve Meyer, former CEO of Welch Allyn, joined PhotoniCare's advisory board to support its mission of improving ear infection diagnosis.
PhotoniCare’s OtoSight Demonstrates More Accurate Diagnosis and a 50% Reduction in Antibiotic Usage in Large Trial
A large randomized trial showed that OtoSight improves diagnosis accuracy and reduces unnecessary antibiotic use in children with ear infections.
Imaging Platform PhotoniCare Wins Top Prize at SPIE Startup Challenge at Photonics West
PhotoniCare's OtoSight Middle Ear Scope won a top prize at SPIE Photonics West, enabling doctors to see through eardrum tissue and visualize middle ear conditions with high resolution.
PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear
PhotoniCare received FDA 510(k) clearance for its OtoSight Middle Ear Scope, a non-invasive imaging device that helps determine the presence and type of fluid in the middle ear.
PhotoniCare Announces Rebranding of First-in-Class Technology for Imaging the Middle Ear, Now called OtoSight Middle Ear Scope
The company rebranded its technology to OtoSight Middle Ear Scope, emphasizing its innovative approach to diagnosing middle ear infections.
PhotoniCare Receives $2.1 Million NIH Phase IIb SBIR Award
PhotoniCare was awarded a $2.1 million grant from NIH to support expanded clinical trials of its OtoSight device for diagnosing middle ear disease.
PhotoniCare Appoints Former Welch Allyn CEO Steve Meyer to Advisory Board
Steve Meyer, former CEO of Welch Allyn, joined PhotoniCare's advisory board to support its mission of improving ear infection diagnosis.
PhotoniCare’s OtoSight Demonstrates More Accurate Diagnosis and a 50% Reduction in Antibiotic Usage in Large Trial
A large randomized trial showed that OtoSight improves diagnosis accuracy and reduces unnecessary antibiotic use in children with ear infections.